002675 Yantai Dongcheng Biochemicals
- 12.11
- +0.10+0.83%
Yantai Dongcheng Biochemicals News
Yantai Dongcheng Biochemicals: Announcement on the Obtaining of State Food and Drug Administration Approval for Technetium (99mTc) Tetrofosmin Injection
Yantai Dongcheng Biochemicals: Announcement regarding the subsidiary company obtaining a drug clinical trial approval notification.
Yantai Dongcheng Biochemicals: Announcement of the implementation of equity distribution in 2023.
Yantai Dongcheng Biochemicals: Announcement Regarding the Launch of Operations at Hefei Nuclear Medicine Production Center.
Yantai Dongcheng Biochemicals: Announcement on the Progress of Providing Guarantees for Subsidiaries and Their Subsidiaries.
Yantai Dongcheng Biochemicals: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials
Yantai Dongcheng Biochemicals: Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Yantai Dongcheng Biochemicals: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Yantai Dongcheng Biochemicals: Announcement on the subsidiary company being recognized as a specialized, special and new small and medium-sized enterprise in Hebei Province
Yantai Dongcheng Biochemicals: 002675 Dongcheng Pharmaceutical Investor Relations Management Information 20240508
Yantai Dongcheng Biochemicals: Notice on subsidiary companies obtaining approval notices for drug clinical trials
Yantai Dongcheng Biochemicals: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials
Yantai Dongcheng Biochemicals: Self-inspection form for the implementation of internal control rules
Yantai Dongcheng Biochemicals: 2023 Annual Audit Report
Yantai Dongcheng Biochemicals: Announcement on 2024 Company and Subsidiaries Applying for Credit Lines from Banks
Yantai Dongcheng Biochemicals: 2023 Annual Report Summary
Yantai Dongcheng Biochemicals: 2023 Independent Director Debriefing Report (Zhao Dayong)
Yantai Dongcheng Biochemicals: Announcement of Supervisory Board Resolutions
Yantai Dongcheng Biochemicals: Internal Control Self-Assessment Report
Yantai Dongcheng Biochemicals: Opinions of Minsheng Securities Co., Ltd. on the deposit and use of funds raised by Yantai Dongcheng Pharmaceutical Group Co., Ltd. in 2023
Analysis
Price Target
No Data
